Influence
July 6, 2026

Office of Strategic Innovation helps connect startups with research expertise

Moving healthcare innovations from promising ideas to real-world impact requires collaboration between researchers, entrepreneurs, healthcare organizations and industry partners.

That collaborative approach brought Regenstrief Institute’s Office of Strategic Innovation (OSI) to the recent IU Labs Life Tech Accelerator, where Paul Biondich, M.D., M.S., was invited to speak with startup founders and researchers participating in the program.

Hosted by IU Labs, the Life Tech Accelerator helps researchers and entrepreneurs develop ideas into viable businesses through mentorship, education and industry partnerships. Throughout the program, founders met with organizations including Lilly’s Catalyze360 team, IU Health, BioCrossroads, TechPoint and Regenstrief to learn from experts, refine their ideas and build new connections.

During the session, Biondich shared Regenstrief’s history of improving health through research and innovation and discussed how OSI helps connect external partners with the Institute’s expertise.

As startup teams presented their technologies and the healthcare challenges they hope to address, Biondich identified opportunities where collaboration with Regenstrief could help advance their work. Following the discussions, he connected startup leaders with Regenstrief investigators and team members whose expertise aligned with their needs.

“It’s exciting to see the campus be supportive of that startup culture,” Biondich said. “And it’s even more exciting to look for opportunities for Regenstrief team members to work alongside some of these startups where it makes sense.”

The event reflects the growing relationship between Regenstrief and IU Labs as both organizations work to build partnerships that accelerate healthcare innovation and improve health.

Related News

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher

Rachel Patzer, PhD, MPH

Building trust in healthcare AI through data and evidence

As artificial intelligence rapidly transforms healthcare, innovation alone is not enough. Health systems need evidence that AI tools are

doctor using electronic health record

Data expertise helps researchers understand how clinical tools are used in real-world care

Regenstrief Data Services (RDS) provided critical health data and specialized expertise to support research examining clinical decision-support use across